| |
| |
|
| Insider
Information: |
Cooper Ronald Harold Wilfred |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,500 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Albireo Pharma Inc |
ALBO |
President and CEO, Dir... |
2023-03-02 |
0 |
2016-11-03 |
0 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
|
2023-01-05 |
9,500 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2023-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(33,094) |
0 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2023-01-23 |
4 |
AS |
$43.80 |
$46,297 |
D/D |
(1,057) |
57,444 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
195,000 |
252,444 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
|
– • – |
2023-01-05 |
4 |
A |
$5.12 |
$48,640 |
D/D |
9,500 |
9,500 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2022-10-24 |
4/A |
AS |
$19.58 |
$17,991 |
D/D |
(919) |
58,501 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2022-10-24 |
4 |
AS |
$19.58 |
$17,991 |
D/D |
(919) |
55,461 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2022-07-22 |
4 |
AS |
$24.67 |
$22,923 |
D/D |
(929) |
56,380 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2022-04-22 |
4 |
AS |
$33.11 |
$30,031 |
D/D |
(907) |
56,082 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2022-01-24 |
4 |
AS |
$24.88 |
$91,666 |
D/D |
(3,684) |
56,989 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2021-09-17 |
4 |
D |
$29.61 |
$229,774 |
D/D |
(7,760) |
60,673 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2021-09-17 |
4 |
OE |
$19.19 |
$229,762 |
D/D |
11,973 |
68,433 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
48,700 |
56,460 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2018-08-14 |
4 |
AB |
$31.63 |
$25,098 |
D/D |
788 |
6,734 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
President and CEO |
• • – |
2016-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,946 |
5,946 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
